Cargando…

Circulating SERPINA3 improves prognostic stratification in patients with a de novo or worsened heart failure

AIMS: We investigated the prognostic relevance of serpin peptidase inhibitor, clade A member 3 (SERPINA3) in patients admitted with a de novo or worsened heart failure (HF). METHODS AND RESULTS: In the first stage, 83 HF‐related left ventricular (LV) transcripts were examined in patients with conges...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delrue, Leen, Vanderheyden, Marc, Beles, Monika, Paolisso, Pasquale, Di Gioia, Giuseppe, Dierckx, Riet, Verstreken, Sofie, Goethals, Marc, Heggermont, Ward, Bartunek, Jozef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712810/ https://www.ncbi.nlm.nih.gov/pubmed/34725968 http://dx.doi.org/10.1002/ehf2.13659

Ejemplares similares

Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients
por: Heggermont, Ward A., et al.
Publicado: (2020)

Hemodynamic Response to Acute Volume Load and Endomyocardial NO-synthase Gene Expression in Heart Transplant Recipients
por: Kobediona, Monika, et al.
Publicado: (2022)

Serial Non-Invasive Myocardial Work Measurements for Patient Risk Stratification and Early Detection of Cancer Therapeutics-Related Cardiac Dysfunction in Breast Cancer Patients: A Single-Centre Observational Study
por: Moya, Ana, et al.
Publicado: (2023)

Utilizing longitudinal data in assessing all‐cause mortality in patients hospitalized with heart failure
por: Herman, Robert, et al.
Publicado: (2022)

T Cell and Antibody Response Following Double Dose of BNT162b2 mRNA Vaccine in SARS-CoV-2 Naïve Heart Transplant Recipients
por: Delrue, Leen, et al.
Publicado: (2022)

Cardio–renal–metabolic syndrome: clinical features and dapagliflozin eligibility in a real‐world heart failure cohort
por: Beles, Monika, et al.
Publicado: (2023)

Detection of transthyretin amyloid cardiomyopathy by automated data extraction from electronic health records
por: Moya, Ana, et al.
Publicado: (2023)

Vessel Fractional Flow Reserve and Graft Vasculopathy in Heart Transplant Recipients
por: Nagumo, Sakura, et al.
Publicado: (2020)

Validation of Coronary Angiography-Derived Vessel Fractional Flow Reserve in Heart Transplant Patients with Suspected Graft Vasculopathy
por: Mileva, Niya, et al.
Publicado: (2021)

Differential expression of epigenetic modifiers in early and late cardiotoxic heart failure reveals DNA methylation as a key regulator of cardiotoxicity
por: Robinson, Emma L., et al.
Publicado: (2023)

Performance of non‐invasive myocardial work to predict the first hospitalization for de novo heart failure with preserved ejection fraction
por: Paolisso, Pasquale, et al.
Publicado: (2021)

Novel IVC Doraya Catheter Provides Congestion Relief in Patients With Acute Heart Failure
por: Zymliński, Robert, et al.
Publicado: (2022)

Safety, Feasibility of Controllable Decrease of Vena Cava Pressure by Doraya Catheter in Heart Failure
por: Zymliński, Robert, et al.
Publicado: (2023)

Recurrent Episodes of Fluid Retention in a Patient with Heart Failure and Chronic Kidney Disease: The Additional Value of Implantable Monitoring Systems
por: Vanderheyden, Marc, et al.
Publicado: (2021)

Integrate and boost: bioscaffolds nurture the cardiac regenerative paradigm
por: Bartunek, Jozef, et al.
Publicado: (2015)

Global longitudinal strain and outcome after endoscopic mitral valve repair
por: Kotrc, Martin, et al.
Publicado: (2022)

Novel device-based interventional strategies for advanced heart failure
por: Toth, Gabor G., et al.
Publicado: (2016)

Aortic thoracic neuromodulation in heart failure with preserved ejection fraction
por: Paolisso, Pasquale, et al.
Publicado: (2022)

Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients
por: Treskes, Roderick W., et al.
Publicado: (2021)

Mitral Valve Repair of Atrial Functional Mitral Regurgitation in Heart Failure with Preserved Ejection Fraction
por: Balogh, Zsuzsanna, et al.
Publicado: (2020)

Deferral of Coronary Revascularization in Patients With Reduced Ejection Fraction Based on Physiological Assessment: Impact on Long‐Term Survival
por: Gallinoro, Emanuele, et al.
Publicado: (2022)

Progressive Thinning of the Basal Interventricular Septum by Giant Cell Myocarditis
por: Iturriagagoitia, Arthur, et al.
Publicado: (2020)

SERPINA2 Is a Novel Gene with a Divergent Function from SERPINA1
por: Marques, Patrícia Isabel, et al.
Publicado: (2013)

Endpoints in stem cell trials in ischemic heart failure
por: Banovic, Marko, et al.
Publicado: (2015)

Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve
por: Gallinoro, Emanuele, et al.
Publicado: (2021)

SERPINA3 in glioblastoma and Alzheimer’s disease
por: Norton, Emily S., et al.
Publicado: (2021)

Expression of SERPINA3s in cattle: focus on bovSERPINA3-7 reveals specific involvement in skeletal muscle
por: Péré-Brissaud, Antoine, et al.
Publicado: (2015)

Serine protease inhibitors serpina1 and serpina3 are down-regulated in bone marrow during hematopoietic progenitor mobilization
por: Winkler, Ingrid G., et al.
Publicado: (2005)

Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β-catenin signal
por: Fang, Weilin, et al.
Publicado: (2023)

SERPINA3: Stimulator or Inhibitor of Pathological Changes
por: de Mezer, Mateusz, et al.
Publicado: (2023)

First report of inherited thyroxine-binding globulin deficiency in Iran caused by a known de novo mutation in SERPINA7
por: Soheilipour, Fahimeh, et al.
Publicado: (2016)

Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device‐induced acquired von Willebrand syndrome
por: Deconinck, Shannen, et al.
Publicado: (2018)

Genome Wide Association Identifies Common Variants at the SERPINA6/SERPINA1 Locus Influencing Plasma Cortisol and Corticosteroid Binding Globulin
por: Bolton, Jennifer L., et al.
Publicado: (2014)

An unexpected cause of a swollen pacemaker pocket: a case report
por: Popelier, Bert, et al.
Publicado: (2022)

Differential overexpression of SERPINA3 in human prion diseases
por: Vanni, S., et al.
Publicado: (2017)

The Association and Pathogenesis of SERPINA3 in Coronary Artery Disease
por: Li, Bo, et al.
Publicado: (2021)

Increased SERPINA3 Level Is Associated with Ulcerative Colitis
por: Zhang, Jingwei, et al.
Publicado: (2021)

Contemporary Management of Stable Coronary Artery Disease
por: Bertolone, Dario Tino, et al.
Publicado: (2022)

Genetic variants in SERPINA4 and SERPINA5, but not BCL2 and SIK3 are associated with acute kidney injury in critically ill patients with septic shock
por: Vilander, Laura M., et al.
Publicado: (2017)

Identification and characterisation of eight novel SERPINA1 Null mutations
por: Ferrarotti, Ilaria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vg2blkp3c9sn0rp5gvnh6jqoh2